Featured Research

from universities, journals, and other organizations

Deadly infection more common than realized

Date:
December 23, 2009
Source:
University of Gothenburg
Summary:
Staphylococcus aureus causes far more serious infections than previously realized.

Staphylococcus aureus causes far more serious infections than previously realised, with more than 3,000 Swedes affected every year, reveals a thesis from the Sahlgrenska Academy at the University of Gothenburg, Sweden.

To date there have been no reliable data on just how common this often deadly infection is, but previously it has been estimated that just over 2,000 people are affected each year in Sweden. A population-based review of cases in the county of Skaraborg has shown that this estimate was far too low, and that the actual figure is at least 3,000 cases per annum.

"The infection can be hard to detect as it doesn't always result in a fever," says consultant Gunnar Jacobsson, who wrote the thesis. "Now that we know that it is so common, we have to be more observant with patients who have non-specific signs of infection such as a rapid pulse and difficulty breathing."

Unlike many other bacterial infections, it is not possible to vaccinate against Staphylococcus aureus. This is because the antibodies that result from vaccination are not considered to protect against new infections, though the thesis shows that the antibodies do, in fact, have a role to play.

"Those patients who had lower levels of antibodies were more likely to develop complications and die," says Jacobsson. "So it would seem that the antibodies do play some role in the body's defence system, and that a vaccine would perhaps not be without some effect."

Staphylococcus aureus

Staphylococcus aureus bacteria are often found on our skin and in our nose, where they are not dangerous. However, the bacteria can infect the body through wounds and cause septicaemia. The elderly and the infirm are most vulnerable, and anyone who is not treated with antibiotics quickly has a high risk of dying: 20 per cent of patients who contract a serious infection die within a month.

Thesis: Invasive Staphylococcus aureus infections


Story Source:

The above story is based on materials provided by University of Gothenburg. Note: Materials may be edited for content and length.


Cite This Page:

University of Gothenburg. "Deadly infection more common than realized." ScienceDaily. ScienceDaily, 23 December 2009. <www.sciencedaily.com/releases/2009/12/091222104911.htm>.
University of Gothenburg. (2009, December 23). Deadly infection more common than realized. ScienceDaily. Retrieved July 22, 2014 from www.sciencedaily.com/releases/2009/12/091222104911.htm
University of Gothenburg. "Deadly infection more common than realized." ScienceDaily. www.sciencedaily.com/releases/2009/12/091222104911.htm (accessed July 22, 2014).

Share This




More Health & Medicine News

Tuesday, July 22, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins